B. Braun Ceftazidime Duplex Container for Injection USP and Dextrose Injection USP (24/Case)

Yes, the B. Braun Ceftazidime Duplex Container is fully compliant with stringent regulatory standards. It meets the requirements set forth by both:

• The Joint Commission
• USP 797 guidelines

Yes, the B. Braun Ceftazidime Duplex Container is specifically engineered to integrate seamlessly into modern hospital workflows, including automated dispensing systems.

This compatibility offers significant benefits for workflow and safety:

• System Integration: The container works efficiently in conjunction with automated dispensing equipment, streamlining pharmacy processes.
• Enhanced Safety and Traceability: An integrated barcode references the final drug admixture, which helps ensure correct drug identification and supports accurate, automated charting.
• Efficiency: The design simplifies labeling and dispensing protocols, contributing to reduced medication errors.

Yes, the B. Braun Ceftazidime Duplex Container utilizes a closed system design. This feature is crucial for maintaining medication integrity and enhancing safety for both patients and healthcare providers.

Key advantages of the closed system include:

• Enhanced Safety: The design prevents mixing errors; the diluent cannot be administered without the drug component being present.
• Contamination Prevention: It prevents external contamination, ensuring the pre-measured drug and diluent remain sterile until immediately prior to use.
• Potency Protection: The closed environment protects the medication’s efficacy and allows for a long 24-month shelf life at room temperature without requiring thawing.
• Compliance: This system meets stringent industry standards, including the Joint Commission and USP 797 guidelines.
• Personnel Protection: It helps protect staff by guarding against exposure to airborne cephalosporins.

Yes, the B. Braun Duplex Container is an innovative, ready-to-use, closed IV system specifically engineered to ensure maximum dosing accuracy and safety.

Here are the details regarding the pre-filled dosing:

• Eliminates Errors: The container is factory pre-filled with the exact, measured doses of the drug (Ceftazidime) and the diluent (Dextrose Injection USP). This removes the need for manual reconstitution, vials, or measuring, significantly reducing preparation errors.
• Available Configurations: The product is available in precise dosages of 1 Gram or 2 Grams. Both configurations deliver a standard final volume of 50 mL.
• Enhanced Safety: The closed, two-compartment system ensures the diluent cannot be delivered without the medication being present and mixed, enhancing medication safety.
• Convenience: Activation is simple, requiring only folding and squeezing the bag at the patient’s bedside just prior to administration. The product has a 24-month shelf life and does not require thawing, as it can be stored at room temperature.

Yes, this product utilizes an advanced Duplex two-compartment flexible IV container system designed for enhanced medication safety and user convenience. This specialized design keeps the drug (Ceftazidime) and the diluent (Dextrose) separate until the point of use, maintaining stability and potency.

Key benefits of this closed duplex system include:

• Ready-to-Use Format: No mixing, thawing, or special bedside vials are required. Activation is achieved simply by folding and squeezing the bag at the patient’s bedside to combine the components.
• Enhanced Medication Safety: It operates as a closed system, which significantly reduces the potential for mixing errors and protects against contamination.
• Material Compliance: For optimal patient safety, the container is not made with latex, PVC, or DEHP, and it fully complies with stringent Joint Commission and USP 797 guidelines.
• Convenient Storage: The containers boast a 24-month total shelf life and can be stored conveniently at room temperature.

Yes, the B. Braun Ceftazidime Duplex Container is specifically designed as a ready-to-use closed system that significantly minimizes potential errors and associated medication waste in clinical settings. This is achieved through several key features:

• Pre-Measured Dosing: Each container includes an accurate, pre-measured dose of the drug (Ceftazidime) and the diluent (Dextrose Injection USP). This eliminates the need for manual compounding, reducing measurement errors and waste common with separate vials.
• Enhanced Safety: The inherent closed-system design ensures the diluent cannot be administered without the drug component being present, reducing the risk of mixing errors.
• Potency Protection: By keeping the drug and diluent separate until the moment of use (activated by folding and squeezing), the system prevents contamination and protects the medication’s efficacy, avoiding the need to discard doses due to sterility concerns.
• Simplified Preparation: The system requires no thawing and is activated at the bedside, streamlining workflow and reducing administrative waste.

Each case of the B. Braun Ceftazidime Duplex Container includes 24 units.

The B. Braun Duplex Container system offers highly convenient, pre-measured strengths of Ceftazidime for Injection USP, designed to simplify preparation and enhance medication safety.The available dosages are:* 1 Gram* 2 GramsBoth dosages are standardized for administration in a 50 mL volume of Dextrose Injection USP diluent.This ready-to-use format eliminates the need for complex mixing or manual reconstitution, reducing the risk of medication errors. Each case contains 24 individual duplex containers. The product also boasts a 24-month total shelf life and can be stored at room temperature, requiring no thawing.

The B. Braun Duplex Container features several advanced safeguards to protect patients, medication potency, and healthcare staff.

• Closed System Integrity: The two-compartment design maintains a closed system that prevents external contamination and protects medication efficacy. This design also safeguards staff by protecting against exposure to airborne cephalosporins.
• Enhanced Medication Safety: It significantly reduces mixing errors because the system is designed so the diluent (Dextrose Injection USP) cannot be administered without the Ceftazidime medication. This ready-to-use format eliminates complex manual preparation.
• Material and Environmental Safety: The container is manufactured without latex, PVC, or DEHP, minimizing potential patient risks. Furthermore, its composition prevents the release of harmful dioxins during disposal.
• Compliance and Traceability: This system adheres to strict regulatory standards, meeting both Joint Commission and USP 797 guidelines. Additionally, the integrated barcode references the final admixture, aiding in correct drug identification and automated charting.

The B. Braun Ceftazidime Duplex Container is a ready-to-use system designed for simple, immediate activation, often at the patient’s bedside. It eliminates the need for separate vials, complex mixing, or thawing.

To mix the components, simply fold and squeeze the bag to rupture the internal seal. This action instantly combines the two separate chambers:

• The drug component: Ceftazidime for Injection USP
• The diluent component: Dextrose Injection USP

The resulting standardized 50 mL admixture is prepared in a closed system, which ensures potency protection and prevents contamination prior to IV administration.